Share the Video:

Breaking New Ground: Next-Generation Drug Development Programs

Adrienne Jo, Dillan DiNardo, Jacob Hooker, Alex Speiser

Beyond MDMA and psilocybin, a new wave of psychedelic-inspired compounds is in development. This panel brings together biotech leaders to discuss novel molecules, delivery methods, and therapeutic targets—and what it takes to move from early discovery to clinical relevance in a crowded and evolving field.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos